Don’t forget you can visit MyAlerts to manage your alerts at any time.
By Scott Graham | May 1, 2017
The U.S. Court of Appeals for the Federal Circuit ruled a drug used to treat chemotherapy symptoms did not avoid the on-sale bar for patents despite keeping some details of its drug sale confidential.
1 minute read
By Jason Grant | May 1, 2017
A federal judge in Massachusetts ruled Manhattan plaintiffs firm Milberg "implemented an elaborate scheme of misrepresentation and deceit under the guise of a legitimate medical research study" and dismissed a plaintiff's qui tam action.
1 minute read
By P.J. D'Annunzio | May 1, 2017
There will be no second chance for a dismissed False Claims Act case pursued by a whistleblower and numerous government entities alleging that Genentech suppressed data about Avastin, a federal appeals court has decided.
1 minute read
By Charles Toutant | April 26, 2017
Already under scrutiny from lawmakers over pricing of its EpiPen epinephrine injector, Mylan faces new lawsuits from consumers and a competitor in New Jersey federal courts accusing it of taking anti-competitive actions to protect its product's market share.
1 minute read
By Amanda Bronstad | April 24, 2017
The first bellwether trial over blood thinner Xarelto began on Monday in New Orleans—but it's not just your ordinary case involving a pharmaceutical drug.
1 minute read
By Roy Strom | April 20, 2017
A Chicago federal jury on Thursday awarded $3 million to the widow of a former leader of Reed Smith's corporate department, finding pharmaceutical giant GlaxoSmithKline plc liable for the 2010 suicide of Stewart Dolin.
1 minute read
By Tom McParland | April 20, 2017
A Delaware federal judge has allowed Amgen Inc. to pursue enhanced damages in its patent infringement dispute with a rival drugmaker, the latest development to a case with billions of dollars on the line.
1 minute read
By Ben Hancock | April 20, 2017
The involvement of former Juridica CEO Richard Fields raises questions as to whether litigation funders may be turning to social impact cases.
1 minute read
By Anna Zhang | April 20, 2017
The Osaka-based generic drugmaker is buying Minnesota-based Upsher-Smith Laboratories Inc.
1 minute read
By Max Mitchell | April 19, 2017
The first lawsuit filed in Pennsylvania over the shingles vaccine has been dismissed with a federal judge saying the suit was begun after the statute of limitations had run out.
1 minute read
Presented by BigVoodoo
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS